TAUNS LaboratoriesInc Balance Sheet Health
Financial Health criteria checks 5/6
TAUNS LaboratoriesInc has a total shareholder equity of ¥13.7B and total debt of ¥9.5B, which brings its debt-to-equity ratio to 69.8%. Its total assets and total liabilities are ¥29.3B and ¥15.6B respectively. TAUNS LaboratoriesInc's EBIT is ¥8.0B making its interest coverage ratio 341.3. It has cash and short-term investments of ¥9.4B.
Key information
69.8%
Debt to equity ratio
JP¥9.54b
Debt
| Interest coverage ratio | 341.3x |
| Cash | JP¥9.42b |
| Equity | JP¥13.67b |
| Total liabilities | JP¥15.59b |
| Total assets | JP¥29.26b |
Recent financial health updates
No updates
Recent updates
Financial Position Analysis
Short Term Liabilities: 197A's short term assets (¥16.9B) exceed its short term liabilities (¥10.5B).
Long Term Liabilities: 197A's short term assets (¥16.9B) exceed its long term liabilities (¥5.1B).
Debt to Equity History and Analysis
Debt Level: 197A's net debt to equity ratio (0.8%) is considered satisfactory.
Reducing Debt: Insufficient data to determine if 197A's debt to equity ratio has reduced over the past 5 years.
Debt Coverage: 197A's debt is well covered by operating cash flow (104.2%).
Interest Coverage: 197A's interest payments on its debt are well covered by EBIT (341.3x coverage).